{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:14:32Z","timestamp":1783329272911,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C52915\/A29104"],"award-info":[{"award-number":["C52915\/A29104"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000866","name":"Cardiff University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201236","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:48:06Z","timestamp":1778770086000},"page":"201236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the in vivo biodistributions of \u03b1v\u03b26-binding agents for PET imaging applications"],"prefix":"10.1016","volume":"34","author":[{"given":"Emma A.","family":"Swift","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Paisey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby J.","family":"Phesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-957X","authenticated-orcid":false,"given":"Rebecca J.","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201236_bib1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1242\/jcs.108.6.2241","article-title":"Expression of the \u03b26 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling","volume":"108","author":"Breuss","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omton.2026.201236_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2174\/138945009788680374","article-title":"Defining the role of integrin alphavbeta6 in cancer","volume":"10","author":"Bandyopadhyay","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.omton.2026.201236_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201236_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(01)03280-X","article-title":"The integrin \u03b1V\u03b26 binds and activates latent TGF\u03b23","volume":"511","author":"Annes","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omton.2026.201236_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/jop.12044","article-title":"Expression of \u03b1v\u03b26 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications","volume":"42","author":"Li","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.omton.2026.201236_bib6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/path.5320","article-title":"The integrin \u03b1v\u03b26 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy","volume":"249","author":"Reader","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.omton.2026.201236_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200523183","article-title":"Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma","volume":"115","author":"Bates","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2026.201236_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clon.2007.09.008","article-title":"Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma","volume":"20","author":"Zhang","year":"2008","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201236_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/002215540205001010","article-title":"Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer","volume":"50","author":"Ahmed","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.omton.2026.201236_bib10","article-title":"Integrin \u03b26 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201236_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/cancers11050674","article-title":"CAR T-Cells Targeting the Integrin \u03b1v\u03b26 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies","volume":"11","author":"Whilding","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2026.201236_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.657868","article-title":"Chimeric Antigen Receptor T Cells Targeting Integrin \u03b1v\u03b26 Expressed on Cholangiocarcinoma Cells","volume":"11","author":"Phanthaphol","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201236_bib13","doi-asserted-by":"crossref","first-page":"e14579","DOI":"10.1200\/JCO.2024.42.16_suppl.e14579","article-title":"TROCEPT: An oncolytic virus platform engineered for \u03b1v\u03b26 integrin targeted tumor-localised expression of an immune checkpoint inhibitor following intravenous delivery","volume":"42","author":"Krige","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201236_bib14","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-18-1089","article-title":"Ad5(NULL)-A20: A Tropism-Modified, \u03b1v\u03b26 Integrin-Selective Oncolytic Adenovirus for Epithelial Ovarian Cancer Therapies","volume":"24","author":"Uusi-Kerttula","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201236_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1078-0432.CCR-14-1194","article-title":"Integrin\u03b26-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma","volume":"21","author":"Liang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201236_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/path.2745","article-title":"High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin \u03b1v\u03b26","volume":"222","author":"Saha","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.omton.2026.201236_bib17","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1158\/0008-5472.CAN-07-1026","article-title":"Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography","volume":"67","author":"Hausner","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201236_bib18","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-16-3217","article-title":"Identification of a Novel ITG\u03b1v\u03b26-Binding Peptide Using Protein Separation and Phage Display","volume":"23","author":"Altmann","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201236_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11307-018-1296-6","article-title":"PET\/CT Imaging of NSCLC with a \u03b1(v)\u03b2(6) Integrin-Targeting Peptide","volume":"21","author":"Flechsig","year":"2019","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.omton.2026.201236_bib20","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/s41467-019-11863-w","article-title":"Evaluation of integrin \u03b1v\u03b26 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis","volume":"10","author":"Kimura","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201236_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00259-021-05559-x","article-title":"PET\/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the \u201cCancer Integrin\u201d \u03b1v\u03b26 with Ga-68-Trivehexin","volume":"49","author":"Quigley","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.omton.2026.201236_bib22","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1078-0432.CCR-18-2665","article-title":"Preclinical Development and First-in-Human Imaging of the Integrin \u03b1(v)\u03b2(6) with [(18)F]\u03b1(v)\u03b2(6)-Binding Peptide in Metastatic Carcinoma","volume":"25","author":"Hausner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201236_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2967\/jnmt.117.203547","article-title":"A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of (18)F-FB-A20FMDV2 for Imaging the Integrin \u03b1(v)\u03b2(6)","volume":"46","author":"Keat","year":"2018","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.omton.2026.201236_bib24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2967\/jnumed.118.210013","article-title":"Comparison of the RGD Motif\u2013Containing \u03b1v\u03b26 Integrin\u2013Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC","volume":"59","author":"Roesch","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.omton.2026.201236_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cbpa.2021.06.008","article-title":"Reducing the renal retention of low- to moderate-molecular-weight radiopharmaceuticals","volume":"63","author":"Chigoho","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.omton.2026.201236_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2023.1271208","article-title":"Mini review of first-in-human integrin \u03b1v\u03b26 PET tracers","volume":"3","author":"Kimura","year":"2023","journal-title":"Front. Nucl. Med."},{"key":"10.1016\/j.omton.2026.201236_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2967\/jnumed.114.150680","article-title":"The Effect of Bi-Terminal PEGylation of an Integrin \u03b1v\u03b26-Targeted 18F Peptide on Pharmacokinetics and Tumor Uptake","volume":"56","author":"Hausner","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.omton.2026.201236_bib28","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.75.6.2972-2981.2001","article-title":"Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells","volume":"75","author":"Jakubczak","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2026.201236_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/v13050864","article-title":"Efficient Intravenous Tumor Targeting Using the alphavbeta6 Integrin-Selective Precision Virotherapy Ad5NULL-A20","volume":"13","author":"Davies","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2026.201236_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmb.2008.07.013","article-title":"Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus","volume":"382","author":"Kogelberg","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omton.2026.201236_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymthe.2016.10.012","article-title":"Targeting of Aberrant \u03b1v\u03b26 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells","volume":"25","author":"Whilding","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201236_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7150\/thno.7811","article-title":"Dimerization of a phage-display selected peptide for imaging of \u03b1v\u03b26- integrin: two approaches to the multivalent effect","volume":"4","author":"Singh","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.omton.2026.201236_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/bc970182v","article-title":"Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity","volume":"9","author":"Wilbur","year":"1998","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omton.2026.201236_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.omton.2026.201236_bib35","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2967\/jnumed.118.223636","article-title":"The Impact of Fc\u03b3RI Binding on Immuno-PET","volume":"60","author":"Vivier","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.omton.2026.201236_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100657","article-title":"Optimized serum stability and specificity of an \u03b1v\u03b26 integrin-binding peptide for tumor targeting","volume":"296","author":"Cardle","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201236_bib37","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/molecules27144331","article-title":"Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-\u03b1v\u03b26-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma","volume":"27","author":"Hung","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.omton.2026.201236_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejmech.2017.05.008","article-title":"Structure-activity relationship study of the tumour-targeting peptide A20FMDV2 via modification of Lys16, Leu13, and N- and\/or C-terminal functionality","volume":"136","author":"Hung","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omton.2026.201236_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201236_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omton.2026.201236_bib45","article-title":"Protein complex prediction with AlphaFold-Multimer","author":"Evans","year":"2021","journal-title":"Preprint at bioRxiv"},{"key":"10.1016\/j.omton.2026.201236_bib46","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows","volume":"41","author":"Hall","year":"1999","journal-title":"Nucleic Acids Symp. Ser"},{"key":"10.1016\/j.omton.2026.201236_bib39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nprot.2010.13","article-title":"Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine","volume":"5","author":"Vosjan","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omton.2026.201236_bib40","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1039\/C5DT04774A","article-title":"Scaling-down antibody radiolabeling reactions with zirconium-89","volume":"45","author":"Knight","year":"2016","journal-title":"Dalton Trans."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:17:35Z","timestamp":1783325855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926001128"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201236","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the in vivo biodistributions of \u03b1v\u03b26-binding agents for PET imaging applications","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201236"}}